• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Financial Services·601818.SS
Share

China Everbright Bank Company Limited Stocks

CN¥ 3.14Last Updated 02.11.2026

Issuer Rating

5/7
Performance

Strong

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 27.50B

CN¥ 3.14
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

China Everbright Bank Company Limited delivers a wide spectrum of financial solutions and services to a diverse clientele, encompassing corporate enterprises, government bodies, and individual retail customers. Its operations span multiple international locations, including Mainland China, Hong Kong, Luxembourg, Seoul, and Sydney. The institution is structured into several key segments: Corporate Banking, Retail Banking, Financial Market Business, and other ancillary activities. The bank's offerings include various deposit options such as demand, term, collateralized, and notice accounts, alongside specialized RMB general and agreement deposits, structured deposit products, and certificates of deposit. Its lending portfolio features working capital loans, fixed asset financing, project funding, syndicated loans, entrusted loans, auto loans, personal advances, and overdraft facilities. Customers also have access to credit and debit cards. Beyond core banking, the company provides an extensive array of specialized financial services. These comprise bills acceptance, investment banking, trade finance, agency services, cash management, financial consulting and advisory, remittance and settlement, guarantees, wealth management, and securities brokerage. It also engages in inter-bank money market transactions, investment activities, repurchase agreements, equity investments, leasing, capital market operations, asset management, treasury functions, and custodial services. Digital platforms further enhance its service delivery with online, mobile, and private banking options. Furthermore, China Everbright Bank is an active participant in trading debt instruments, derivatives, and foreign exchange. Founded in 1992, its corporate headquarters are situated in Beijing, China.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, underpriced on P/RIBP. Editor's note: P/

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 601818.SS is 3.40 and suggests 9.68% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.11.2026 17:30

Shares of biotech company Inovio soared 240% following the drug's approval. Is there still upside potential?

02.11.2026 17:08

"Hope for a Breakthrough in the Iran Stalemate": Oil Prices Plunge 4%

02.11.2026 16:18

Morning in New York: The High-Tech Sector Cools Off Ahead of the Election

02.11.2026 16:04

"I know he's an idiot": Ryanair CEO assesses the business benefits of his feud with Musk

02.11.2026 15:50

A "Cleaning-Out" Pullback: Morgan Stanley Suggests Entering the Market Ahead of a Rally to 8,000 Points

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026